
Zirus Antivirotics

Zirus
antivirotics, featured, gene trap, H1N1, influenza, macrophage, Pandemic, Swine Flu, Vaccine, viral infection, Zirus, XVIVO
Scientists at Zirus are working on a new technology platform to cure and manage viral infection through the development of new classes of antivirotics. This animation depicts the life cycle of H1N1 influenza-A virus and the methodology Zirus uses to find appropriate targets.
Watch the NPR featured story on Zirus Antivirotics by Robert Krulwich.
“I recently worked with XVIVO on a lengthy and complex video for a new sleep medication that incorporated many different elements: live action, medical animation, abstract/artistic animation, music, and voice over. The end result was excellent; I couldn’t possibly have been more pleased with the results or the process.”
VP, Associate Creative Director, Revolution Health